Results of simultaneous radon and thoron measurements in 33 metropolitan areas of Canada.

Radon has been identified as the second leading cause of lung cancer after tobacco smoking. (222)Rn (radon gas) and (220)Rn (thoron gas) are the most common isotopes of radon. In order to assess thoron contribution to indoor radon and thoron exposure, a survey of residential radon and thoron concentrations was initiated in 2012 with ∼4000 homes in the 33 census metropolitan areas of Canada. The survey confirmed that indoor radon and thoron concentrations are not correlated and that thoron concentrations cannot be predicted from widely available radon information. The results showed that thoron contribution to the radiation dose varied from 0.5 to 6% geographically. The study indicated that, on average, thoron contributes ∼3% of the radiation dose due to indoor radon and thoron exposure in Canada. Even though the estimated average thoron concentration of 9 Bq m(-3) (population weighted) in Canada is low, the average radon concentration of 96 Bq m(-3) (population weighted) is more than double the worldwide average indoor radon concentration. It is clear that continued efforts are needed to further reduce the exposure and effectively reduce the number of lung cancers caused by radon.